DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy by SINICROPE, Frank A, FOSTER, Nathan R, SARGENT, Daniel J, THIBODEAU, Stephen N, MARSONI, Silvia, MONGES, Genevieve, LABIANCA, Roberto, YOTHERS, Greg, ALLEGRA, Carmen, MOORE, Malcolm J, GALLINGER, Steven

Get full text

62 by Matz, F. P., Zerr, G. B. M., Yothers, J. F.

Get full text

63 by Calderhead, J. A., Berg, P. S., Robbins, Edward R., Honey, Frederick R., Zerr, G. B. M., Yothers, J. F.

Get full text

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial by Allegra, Carmen J, Yothers, Greg, O'Connell, Michael J, Beart, Robert W, Wozniak, Timothy F, Pitot, Henry C, Shields, Anthony F, Landry, Jerome C, Ryan, David P, Arora, Amit, Evans, Lisa S, Bahary, Nathan, Soori, Gamini, Eakle, Janice F, Robertson, John M, Moore, Jr, Dennis F, Mullane, Michael R, Marchello, Benjamin T, Ward, Patrick J, Sharif, Saima, Roh, Mark S, Wolmark, Norman

Get full text

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper by Dasari, Arvind, Morris, Van K., Allegra, Carmen J., Atreya, Chloe, Benson, Al B., Boland, Patrick, Chung, Ki, Copur, Mehmet S., Corcoran, Ryan B., Deming, Dustin A., Dwyer, Andrea, Diehn, Maximilian, Eng, Cathy, George, Thomas J., Gollub, Marc J., Goodwin, Rachel A., Hamilton, Stanley R., Hechtman, Jaclyn F., Hochster, Howard, Hong, Theodore S., Innocenti, Federico, Iqbal, Atif, Jacobs, Samuel A., Kennecke, Hagen F., Lee, James J., Lieu, Christopher H., Lenz, Heinz-Josef, Lindwasser, O. Wolf, Montagut, Clara, Odisio, Bruno, Ou, Fang-Shu, Porter, Laura, Raghav, Kanwal, Schrag, Deborah, Scott, Aaron J., Shi, Qian, Strickler, John H., Venook, Alan, Yaeger, Rona, Yothers, Greg, You, Y. Nancy, Zell, Jason A., Kopetz, Scott

Get full text

67 by Priest, F. M., Zerr, G. B. M., Berg, P. S., Scheffer, J., Colaw, J. M., Wagoner, R. H., Yothers, J. F., Fairchild, J. T., Cross, Chas. C., Westcost, O. S., Schmitt, Cooper D., Harvey, W. H., Finkel, B. F.

Get full text

National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22–24, 2009 by Allegra, Carmen J., Aberle, Denise R., Ganschow, Pamela, Hahn, Stephen M., Lee, Clara N., Millon-Underwood, Sandra, Pike, Malcolm C., Reed, Susan D., Saftlas, Audrey F., Scarvalone, Susan A., Schwartz, Arnold M., Slomski, Carol, Yothers, Greg, Zon, Robin

Get full text

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Dat... by Sargent, D, Shi, Q, Yothers, G, Van Cutsem, E, Cassidy, J, Saltz, L, Wolmark, N, Bot, B, Grothey, A, Buyse, M, de Gramont, A

Get full text

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database by Wagner, Anna D, Grothey, Axel, Andre, Thierry, Dixon, Jesse G, Wolmark, Norman, Haller, Daniel G, Allegra, Carmen J, de Gramont, Aimery, VanCutsem, Eric, Alberts, Steven R, George, Thomas J, O’Connell, Michael J, Twelves, Christopher, Taieb, Julien, Saltz, Leonard B, Blanke, Charles D, Francini, Edoardo, Kerr, Rachel, Yothers, Greg, Seitz, Jean F, Marsoni, Silvia, Goldberg, Richard M, Shi, Qian

Get full text

Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials by Yothers, Greg, Sargent, Daniel J., Wolmark, Norman, Goldberg, Richard M., O'Connell, Michael J., Benedetti, Jacqueline K., Saltz, Leonard B., Dignam, James J., Blackstock, A. William

Get full text

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer by Kennecke, Hagen F, Auer, Rebecca, Cho, May, Dasari, N Arvind, Davies-Venn, Cynthia, Eng, Cathy, Dorth, Jennifer, Garcia-Aguilar, Julio, George, Manju, Goodman, Karyn A, Kreppel, Lillian, Meyer, Joshua E, Monzon, Jose, Saltz, Leonard, Schrag, Deborah, Smith, J Joshua, Zell, Jason A, Das, Prajnan

Get full text

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative: Eur J Cancer by Cohen, R., Vernerey, D., Bellera, Carine, Meurisse, A., Henriques, J., Paoletti, X., Rousseau, B., Alberts, S., Aparicio, T., Boukovinas, I., Gill, S., Goldberg, R. M., Grothey, A., Hamaguchi, T., Iveson, T., Kerr, R., Labianca, R., Lonardi, S., Meyerhardt, J., Paul, J., Punt, C. J. A., Saltz, L., Saunders, M. P., Schmoll, H. J., Shah, M., Sobrero, A., Souglakos, I., Taieb, J., Takashima, A., Wagner, A. D., Ychou, M., Bonnetain, F., Gourgou, S., Yoshino, T., Yothers, G., de Gramont, A., Shi, Q., Andre, T.

Get full text

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial by Allegra, Carmen J, Yothers, Greg, O'Connell, Michael J, Beart, Robert W, Wozniak, Timothy F, Pitot, Henry C, Shields, Anthony F, Landry, Jerome C, Ryan, David P, Arora, Amit, Evans, Lisa S, Bahary, Nathan, Soori, Gamini, Eakle, Janice F, Robertson, John M, Moore, Dennis F, Mullane, Michael R, Marchello, Benjamin T, Ward, Patrick J, Sharif, Saima, Roh, Mark S, Wolmark, Norman

Get full text